164 related articles for article (PubMed ID: 4019118)
1. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J
Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.
Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT; Smyth JF
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1141-6. PubMed ID: 6541135
[TBL] [Abstract][Full Text] [Related]
3. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative study.
Smyth JF; Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT
Semin Oncol; 1984 Sep; 11(3 Suppl 1):15-8. PubMed ID: 6484578
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB
Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.
Allegra JC; Woodcock T; Woolf S; Henderson IC; Bryan S; Reisman A; Dukart G
Invest New Drugs; 1985; 3(2):153-61. PubMed ID: 3894278
[TBL] [Abstract][Full Text] [Related]
7. First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.
Periti P; della Cuna GR; Pannuti F; Mazzei T; Preti P; Martoni A; Mini E
Invest New Drugs; 1985; 3(2):167-71. PubMed ID: 4019120
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone as a first-line treatment of advanced breast cancer.
Landys K; Borgstrom S; Andersson T; Noppa H
Invest New Drugs; 1985; 3(2):133-7. PubMed ID: 4019117
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone in malignant lymphoma.
Gams RA; Bryan S; Dukart G; Weiss A; Case D; Jones S; Stein R
Invest New Drugs; 1985; 3(2):219-22. PubMed ID: 4019123
[TBL] [Abstract][Full Text] [Related]
10. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D
Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
Coleman RE; Maisey MN; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours.
Stuart-Harris RC; Smith IE
Cancer Chemother Pharmacol; 1982; 8(2):179-82. PubMed ID: 7105382
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G
Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Meyer P; Ho AD; Ehninger G; Mjaaland I; Heidemann E; Seither E
Invest New Drugs; 1985; 3(2):203-6. PubMed ID: 3860490
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.
Mouridsen HT; Rose C; Nooy MA; van Oosterom AT
Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734
[TBL] [Abstract][Full Text] [Related]
16. First-line mitoxantrone chemotherapy for advanced breast cancer.
Wilson KS; Paterson AH
Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone: an overview of safety and toxicity.
Posner LE; Dukart G; Goldberg J; Bernstein T; Cartwright K
Invest New Drugs; 1985; 3(2):123-32. PubMed ID: 3894276
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.
Knight WA; Von Hoff DD; Neidhart JA; Tranum BL; Fabian C; Jones SE
Invest New Drugs; 1983; 1(2):181-4. PubMed ID: 6678866
[TBL] [Abstract][Full Text] [Related]
19. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
